NDC 36987-2725
Linden
Linden
Linden is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Tilia Americana Pollen.
| Product ID | 36987-2725_0d62fd2a-d535-41ba-b17b-cf1e1f8b216b |
| NDC | 36987-2725 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Linden |
| Generic Name | Linden |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | TILIA AMERICANA POLLEN |
| Active Ingredient Strength | 10000 [PNU]/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2725-3
30 mL in 1 VIAL, MULTI-DOSE (36987-2725-3)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2725-3 [36987272503]
Linden INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2725-2 [36987272502]
Linden INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2725-1 [36987272501]
Linden INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2725-4 [36987272504]
Linden INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TILIA AMERICANA POLLEN | 10000 [PNU]/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Linden" or generic name "Linden"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2725 | Linden | Linden |
| 36987-2726 | Linden | Linden |
| 36987-2727 | Linden | Linden |
| 36987-2728 | Linden | Linden |
| 36987-2729 | Linden | Linden |
| 36987-2730 | Linden | Linden |
| 36987-2731 | Linden | Linden |
| 36987-2732 | Linden | Linden |
Trademark Results [Linden]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LINDEN 90310252 not registered Live/Pending |
DELTA FAUCET COMPANY 2020-11-10 |
 LINDEN 86761105 5098371 Live/Registered |
Yang, Roger 2015-09-18 |
 LINDEN 86361010 not registered Live/Pending |
DELTA FAUCET COMPANY 2014-08-08 |
 LINDEN 77946379 not registered Dead/Abandoned |
Natura World Inc. 2010-02-26 |
 LINDEN 76402825 3024052 Live/Registered |
Linden Life Science LLC 2002-05-02 |
 LINDEN 76344371 2695042 Live/Registered |
Linden Vineyards, Ltd. 2001-12-04 |
 LINDEN 76341691 2692496 Dead/Cancelled |
Kabushiki Kaisha Kawai Gakki Seisakusho 2001-11-26 |
 LINDEN 75042129 not registered Dead/Abandoned |
Kabushiki Kaisha Kawai Gakki Seisakusho 1996-01-11 |
 LINDEN 74632836 1996202 Dead/Cancelled |
HAAS TCM INC. 1995-02-10 |
 LINDEN 74529338 not registered Dead/Abandoned |
PARK LANE ASSOCIATES, INC. 1994-05-25 |
 LINDEN 74322736 not registered Dead/Abandoned |
LENOX, INCORPORATED 1992-10-16 |
 LINDEN 74184648 1783275 Dead/Cancelled |
VELBON INTERNATIONAL CORPORATION 1991-07-12 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.